Home/Filings/4/0001628280-25-033187
4//SEC Filing

Xian Ming 4

Accession 0001628280-25-033187

CIK 0000910329other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 7:06 PM ET

Size

8.7 KB

Accession

0001628280-25-033187

Insider Transaction Report

Form 4
Period: 2025-06-25
Xian Ming
Director
Transactions
  • Award

    Restricted Stock Units (cash settled)

    2025-06-25$13.39/sh+6,013.35$80,51932,142.918 total
    Common Stock (6,013.35 underlying)
  • Award

    Restricted Stock Units (cash settled)

    2025-06-25+11,167.6526,129.568 total
    Common Stock (11,167.65 underlying)
Footnotes (3)
  • [F1]Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.
  • [F2]The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.
  • [F3]The price per share of $13.39 is based on the 20-day moving average price of the Issuer's common stock as of June 6, 2025.

Issuer

MEDIFAST INC

CIK 0000910329

Entity typeother

Related Parties

1
  • filerCIK 0001743879

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 7:06 PM ET
Size
8.7 KB